Hofseth Biocare ASA: PROXIES TO VOTE FOR 20.06 % OF THE SHARES AT EGM - DISCLOSURE OF LARGE SHAREHOLDING
24 March 2017 - 1:10AM
Roger Hofseth has, in his
capacity as chairman of the board of directors, received proxies to
vote for 46,838,168 shares in Hofseth BioCare ASA (the "Company"),
corresponding to 20.06 % of the total outstanding shares and votes
at the Company's extraordinary general meeting to be held at 24
March 2017. The proxies received are only valid for the general
meeting and will lapse thereafter.
Roger Hofseth, through his
wholly owned company Roger Hofseth AS, owns 37,217,701 shares in
the Company and may, together with the received proxies, vote for
84,055,869 shares, corresponding to 36.01 % of the votes.
For further information,
please contact:
Tor Erik Andersen, CEO of
Hofseth BioCare ASA
Mob: +47 911 79 854
E-mail: tea@hofsethbiocare.no
Jon Olav Ødegård, CFO of
Hofseth BioCare ASA
Phone: +47 936 32 966
E-mail: joo@hofsethbiocare.no
About Hofseth BioCare
ASA:
HBC is a Norwegian biotech company that offers high-value
ingredients and finished products for humans and pets. The company
is founded on the core values of sustainability, traceability and
optimal utilization of natural resources. Through an innovative
hydrolysis technology, HBC is able to preserve the quality of
salmon oil, proteins and calcium, prepared of fresh salmon
off-cuts. HBC's objective is to contribute to the efficient use of
marine resources and deliver quality products for ingredients and
finished consumer products in the nutrition market.
Hofseth BioCare's
headquarters are located in Ålesund, Norway with branches in Oslo,
Chicago, Mumbai and Tokyo. HBC is listed on Oslo Stock Exchange
Axess list with ticker "HBC". More information about Hofseth
BioCare at www.hofsethbiocare.com and
www.facebook.com/hofsethbiocare
This information is subject
to the disclosure requirements pursuant to section 5-12 of the
Norwegian Securities Trading Act.
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Hofseth Biocare ASA via Globenewswire